The reiteration of a Buy rating and maintenance of a $125 price target by a reputable analyst like Michael Yee from Jefferies is likely to instill confidence among investors and could positively influence Moderna's stock price in the short term. Analyst ratings and price targets are significant indicators for investors, and positive reaffirmations can lead to increased investor interest and potentially drive up the stock price.